Stem Cell Therapy Spinal Cord Injury Review

In this review the authors critically analyze the basic science and translational evidence that supports the use of various stem cell sources including induced pluripotent stem cells oligodendrocyte precursor cells and.

Stem cell therapy spinal cord injury review.

Stem cell therapy is a promising therapeutic option for patients with spinal cord injury. Spinal cord injury sci stem cell therapy unique access provides access to an extensive treatment protocol for spinal cord injury sci which utilises higher quantities of stem cells extensive rehabilitation and many supportive therapies. Stem cell therapy is a potential treatment for spinal cord injury sci and a variety of different stem cell types have been evaluated in animal models and humans with sci. Currently neurorestorative strategies including stem cell therapy products or mature functionally differentiated cell derived cell therapy products can restore patients with chronic complete sci to some degree of neurological functions.

And one promising branch of current medical research is in the direction of stem cell therapy. Spinal cord injury sci is a devastating condition and major burden on society and individuals. Among various types of stem cells bone marrow derived mesenchymal stem cells is highly expected. Therefore new treatment trials with stem cells have been studied to regenerate injured spinal cord.

The only stem cell based products that are fda approved for use in the united states consist of blood forming stem cells hematopoietic progenitor cells derived from cord blood. Cell transplantation as a therapeutic intervention for spinal cord injury sci has been extensively studied by scientists and researchers in recent years using stem cell that has shown considerable promise in treating patients with sci and thus restores lost functions by replacing lost or damaged cell populations. Clinical applications of stem cell based therapies for spinal cord injury sci.